Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
OTC Markets
15:33:28 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 1.670 USD | 0.00% |
|
+11.52% | +35.75% |
| Market Cap | 46.26M 40.1M 37.59M 34.27M 64.49M 4.42B 65.52M 443M 173M 2.21B 174M 170M 7.37B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 44.94M 38.95M 36.52M 33.29M 62.65M 4.29B 63.65M 430M 168M 2.15B 169M 165M 7.16B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +11.52% | ||
| Current month | +10.09% | ||
| 1 month | +1.83% | ||
| 3 months | -16.50% | ||
| 6 months | -9.73% | ||
| Current year | +35.75% |
| 1 week | 1.61 |  | 1.7 |
| 1 month | 1.34 | | 1.7 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.33 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/20/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 1/20/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 2/1/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +11.52% | +77.35% | -7.22% | 46.26M | |
| -1.64% | +13.17% | +94.47% | +452.89% | 45.54B | |
| -0.28% | +2.75% | +19.78% | +47.98% | 26.23B | |
| +0.45% | +0.67% | -19.94% | -34.39% | 7.8B | |
| +0.47% | +15.28% | +21.56% | +145.51% | 6.06B | |
| +0.77% | +4.31% | +20.91% | +71.31% | 3.42B | |
| -3.93% | +13.22% | -32.01% | +1,401.90% | 2.46B | |
| -0.18% | +4.20% | +169.57% | +16.57% | 2.11B | |
| +0.89% | +9.86% | +0.79% | -51.68% | 2.08B | |
| +10.33% | +6.08% | +31.14% | +22.38% | 1.92B | |
| Average | +0.69% | +7.64% | +38.36% | +206.52% | 9.77B | |
| Weighted average by Cap. | -0.63% | +9.38% | +53.37% | +267.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.68M 38.13M 34.77M 65.42M 4.48B 66.47M 449M 175M 2.24B 176M 172M 7.48B | 38.73M 33.57M 31.47M 28.69M 53.99M 3.7B 54.85M 371M 145M 1.85B 145M 142M 6.17B |
| Net income | 6.7M 5.81M 5.45M 4.97M 9.34M 640M 9.49M 64.12M 25.03M 320M 25.16M 24.62M 1.07B | 24.58M 21.3M 19.97M 18.21M 34.26M 2.35B 34.81M 235M 91.79M 1.17B 92.26M 90.26M 3.92B |
| Net Debt | 4.4M 3.81M 3.57M 3.26M 6.13M 419M 6.23M 42.05M 16.42M 210M 16.5M 16.14M 700M | -1.32M -1.15M -1.07M -979K -1.84M -126M -1.87M -12.65M -4.94M -63.16M -4.96M -4.86M -211M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | US$1.670 | 0.00% | 24,225 |
| 26-08-12 | US$1.670 | +0.06% | 2,103 |
| 26-08-11 | US$1.669 | -1.82% | 18,248 |
| 26-08-10 | US$1.700 | +5.59% | 13,703 |
| 26-08-07 | US$1.610 | -1.83% | 501 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
